Routti Jorma 4
4 · FIBROGEN INC · Filed Sep 12, 2018
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Routti Jorma
Director
Transactions
- Sale
Common Stock
2018-09-10$57.19/sh−4,300$245,917→ 133,240 total - Exercise/Conversion
Common Stock
2018-09-10$18.34/sh+6,000$110,040→ 137,540 total - Sale
Common Stock
2018-09-10$57.60/sh−1,700$97,920→ 131,540 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-09-10−6,000→ 6,000 totalExercise: $18.34Exp: 2025-06-03→ Common Stock (6,000 underlying)
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 plan.
- [F2]The shares were sold at prices ranging from $56.55 to $57.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]The shares were sold at prices ranging from $57.55 to $57.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Fully vested.